Integrum: Initial note on the Q3 report - Redeye

Redeye provides its initial take on the Q3’21 report and has a relatively neutral view all in all. A small deviation in expected vs actual performed surgeries results in sales below our estimates. Still, we emphasize its long-term prospects and note important fundaments laid in the quarter. We will return with an update where minor changes to our estimates and Base Case are likely.

Länk till analysen i sin helhet: https://www.redeye.se/research/835349/integrum-initial-note-on-the-q3-report?utm_source=finwire&utm_medium=RSS